Spatial Genomics & Transcriptomics Market Analysis, Application, And Forecast To 2027

The Spatial Genomics and Transcriptomics Market is projected to reach USD 800 million by 2027 from USD 355 million in 2022, at a CAGR of 17.6% during the forecast period. Market growth is largely driven by the shift from strictly research applications to drug discovery & development for areas such as neurodegenerative diseases and cancer. Spatial genomics and transcriptomics are also anticipated to address current unmet clinical needs in oncology, including the demand for predictive biomarkers of response.

Read More Stories: